Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tuning the Tumor Myeloid Microenvironment to Fight Cancer
Nadine S. Jahchan, Adriana M. Mujal, Joshua L. Pollack, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 108

Showing 1-25 of 108 citing articles:

Macrophages as tools and targets in cancer therapy
Alberto Mantovani, Paola Allavena, Federica Marchesi, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 11, pp. 799-820
Open Access | Times Cited: 1033
Enhancing cancer immunotherapy with nanomedicine
Darrell J. Irvine, Eric L. Dane
Nature reviews. Immunology (2020) Vol. 20, Iss. 5, pp. 321-334
Open Access | Times Cited: 664
Harnessing cytokines and chemokines for cancer therapy
David Propper, Frances R. Balkwill
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 4, pp. 237-253
Closed Access | Times Cited: 559
Macrophage-Based Approaches for Cancer Immunotherapy
Nicholas R. Anderson, Nicholas G. Minutolo, Saar Gill, et al.
Cancer Research (2020) Vol. 81, Iss. 5, pp. 1201-1208
Open Access | Times Cited: 485
The NK cell–cancer cycle: advances and new challenges in NK cell–based immunotherapies
Tobias Bald, Matthew F. Krummel, Mark J. Smyth, et al.
Nature Immunology (2020) Vol. 21, Iss. 8, pp. 835-847
Open Access | Times Cited: 365
Targeting TREM2 on tumor-associated macrophages enhances immunotherapy
Mikhail Binnewies, Joshua L. Pollack, Joshua Rudolph, et al.
Cell Reports (2021) Vol. 37, Iss. 3, pp. 109844-109844
Open Access | Times Cited: 211
CytoMAP: A Spatial Analysis Toolbox Reveals Features of Myeloid Cell Organization in Lymphoid Tissues
Caleb Stoltzfus, Jakub Filipek, Benjamin H. Gern, et al.
Cell Reports (2020) Vol. 31, Iss. 3, pp. 107523-107523
Open Access | Times Cited: 195
Tumor-associated macrophages
Luca Cassetta, Jeffrey W. Pollard
Current Biology (2020) Vol. 30, Iss. 6, pp. R246-R248
Open Access | Times Cited: 180
Macrophage targeting in cancer
Martha Lopez‐Yrigoyen, Luca Cassetta, Jeffrey W. Pollard
Annals of the New York Academy of Sciences (2020) Vol. 1499, Iss. 1, pp. 18-41
Open Access | Times Cited: 176
Human Anti-tumor Immunity: Insights from Immunotherapy Clinical Trials
Jackson G. Egen, Wenjun Ouyang, Lawren C. Wu
Immunity (2020) Vol. 52, Iss. 1, pp. 36-54
Open Access | Times Cited: 163
Engineered CAR-Macrophages as Adoptive Immunotherapies for Solid Tumors
Christopher Sloas, Saar Gill, Michael Klichinsky
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 146
Myeloid cell-targeted therapies for solid tumours
Sangeeta Goswami, Swetha Anandhan, Deblina Raychaudhuri, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 2, pp. 106-120
Closed Access | Times Cited: 136
ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation
Xiaozheng Chen, Aiqin Gao, Fang Zhang, et al.
Theranostics (2021) Vol. 11, Iss. 7, pp. 3392-3416
Open Access | Times Cited: 106
Emerging Targeted Therapies for HER2-Positive Breast Cancer
María F. Mercogliano, Sofía Bruni, Florencia Mauro, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 1987-1987
Open Access | Times Cited: 72
YY1 complex in M2 macrophage promotes prostate cancer progression by upregulating IL-6
Saisai Chen, Kai Lǚ, Yue Hou, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 4, pp. e006020-e006020
Open Access | Times Cited: 44
Normalization of the tumor microenvironment by harnessing vascular and immune modulation to achieve enhanced cancer therapy
Yechan Choi, Keehoon Jung
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 11, pp. 2308-2319
Open Access | Times Cited: 38
Natural and Induced Tolerogenic Dendritic Cells
Courtney A. Iberg, Daniel Hawiger
The Journal of Immunology (2020) Vol. 204, Iss. 4, pp. 733-744
Open Access | Times Cited: 131
Targeting a scavenger receptor on tumor-associated macrophages activates tumor cell killing by natural killer cells
Silke Eisinger, Dhifaf Sarhan, Vanessa F. Boura, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 50, pp. 32005-32016
Open Access | Times Cited: 122
The Generation and Identity of Human Myeloid-Derived Suppressor Cells
Caroline Bergenfelz, Karin Leandersson
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 102
Redefining macrophage and neutrophil biology in the metastatic cascade
Esra Güç, Jeffrey W. Pollard
Immunity (2021) Vol. 54, Iss. 5, pp. 885-902
Open Access | Times Cited: 93
Reprogramming immunosuppressive myeloid cells by activated T cells promotes the response to anti-PD-1 therapy in colorectal cancer
Jing Chen, Hong-Wei Sun, Yanyan Yang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 77
27-Hydroxycholesterol acts on myeloid immune cells to induce T cell dysfunction, promoting breast cancer progression
Liqian Ma, Lawrence Wang, Adam Nelson, et al.
Cancer Letters (2020) Vol. 493, pp. 266-283
Open Access | Times Cited: 69
The interferon-stimulated gene RIPK1 regulates cancer cell intrinsic and extrinsic resistance to immune checkpoint blockade
Lisa Cucolo, Qingzhou Chen, Jingya Qiu, et al.
Immunity (2022) Vol. 55, Iss. 4, pp. 671-685.e10
Open Access | Times Cited: 58
Single-cell transcriptomic analysis of human colonic macrophages reveals niche-specific subsets
Diana Domańska, Umair Majid, Victoria T. Karlsen, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 3
Open Access | Times Cited: 57
Necrotic reshaping of the glioma microenvironment drives disease progression
Steven M. Markwell, James Ross, Cheryl L. Olson, et al.
Acta Neuropathologica (2022) Vol. 143, Iss. 3, pp. 291-310
Closed Access | Times Cited: 46
Page 1 - Next Page

Scroll to top